Aug 13, 2026 06:48AM
Aug 12, 2026 07:19AM
Jul 6, 2026 08:42AM
Jul 2, 2026 08:45AM
Jul 1, 2026 07:27AM
Jun 30, 2026 07:05AM
Jun 30, 2026 07:05AM Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)
Jun 29, 2026 07:09AM
Jun 2, 2026 08:41AM
May 13, 2026 06:51AM
May 12, 2026 07:05AM
Apr 9, 2026 07:05AM
Apr 7, 2026 04:31PM
Apr 6, 2026 08:38AM Unicycive Therapeutics (UNCY) PT Lowered to $15 at Benchmark
Apr 2, 2026 06:43AM
Mar 30, 2026 07:05AM
Mar 18, 2026 09:17AM
Mar 16, 2026 09:31AM
Mar 12, 2026 08:14AM
Mar 10, 2026 09:08AM
Mar 5, 2026 09:15AM Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Kyndryl Holdings (NYSE: KD); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UN
Feb 17, 2026 09:15AM
Feb 4, 2026 07:05AM
Jan 29, 2026 09:15AM
Jan 29, 2026 07:05AM
Jan 29, 2026 07:05AM
Dec 30, 2025 06:36AM
Dec 29, 2025 07:05AM Unicycive resubmits drug application for kidney disease treatment
Dec 29, 2025 07:05AM
Dec 3, 2025 09:13AM
Dec 2, 2025 12:39PM
Dec 1, 2025 01:41PM
Nov 25, 2025 07:05AM
Nov 14, 2025 09:26AM
Nov 12, 2025 08:36AM Unicycive Therapeutics (UNCY) PT Lowered to $63 at Lucid Capital Markets
Nov 12, 2025 07:05AM
Nov 10, 2025 09:42AM
Nov 3, 2025 09:10AM
Nov 3, 2025 07:05AM
Oct 30, 2025 07:05AM
Oct 29, 2025 06:49AM
Oct 28, 2025 07:06AM Unicycive expects to resubmit drug application by year-end after FDA meeting
Oct 28, 2025 07:05AM
Oct 27, 2025 10:31AM
Oct 24, 2025 08:44AM
Oct 15, 2025 08:59AM
Oct 8, 2025 08:44AM
Oct 7, 2025 09:31AM
Sep 15, 2025 08:57AM Unicycive Therapeutics (UNCY) PT Raised to $21 at Benchmark to Reflect Reverse Split
Sep 12, 2025 08:38AM

328,517 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All